Surgical and clinical results with the PDN prosthetic disc-nucleus device
- PMID: 12384736
- PMCID: PMC3611569
- DOI: 10.1007/s00586-002-0424-8
Surgical and clinical results with the PDN prosthetic disc-nucleus device
Abstract
The PDN prosthetic disc-nucleus device has been in use for 6 years, both in clinical trials and through commercial sale. Surgical and clinical data for the device have been collected and analyzed to help determine the strengths and limitations of the implant. The shape of the device has been found to be an important element in predicting surgical success, with wedge and rectangular devices being the most stable. The patient's disc dimensions are also critically important. Data indicate that patients with a disc height of less than 5 mm should be excluded from surgery. Moreover, the anterior-posterior (AP) diameter of the disc endplates must be 37 mm or more in order to properly situate two devices within the disc--patients with a smaller AP diameter should receive only a single device. Body mass and overall patient weight are also good predictors of surgical success. If the patient's body mass index is 30 or greater, then the patient should not receive the implants. Complications related to the PDN implant have included migration of the device and endplate remodeling in some patients. This endplate remodeling has usually been mild, and has occurred in response to the change in load distribution. In a few cases there has been more pronounced remodeling with a loss of disc height. To minimize endplate remodeling, the PDN hydrogel has been reformulated to be softer, absorbing 80% of its weight in water. Subsequent to implementing changes in device design and patient selection, and with the introduction of the ALPA (Anterior-Lateral transPsoatic Approach) technique for implanting the devices, there has been an increase in surgical success with a concomitant reduction in the number of revision surgeries. The current surgical success rate for patients implanted from 1999 through 2001 is 88%. Clinical results are also very encouraging, with marked decreases in Oswestry and visual analog scale pain levels, and disc height also shows improvement and stabilization.
Similar articles
-
The PDN prosthetic disc-nucleus device.Eur Spine J. 2002 Oct;11 Suppl 2(Suppl 2):S137-42. doi: 10.1007/s00586-002-0425-7. Epub 2002 Jun 4. Eur Spine J. 2002. PMID: 12384735 Free PMC article. Review.
-
The Anterolateral TransPsoatic Approach (ALPA): a new technique for implanting prosthetic disc-nucleus devices.J Spinal Disord Tech. 2003 Aug;16(4):398-404. doi: 10.1097/00024720-200308000-00012. J Spinal Disord Tech. 2003. PMID: 12902956 Clinical Trial.
-
Prospective, randomized, multicenter Food and Drug Administration investigational device exemption study of lumbar total disc replacement with the CHARITE artificial disc versus lumbar fusion: five-year follow-up.Spine J. 2009 May;9(5):374-86. doi: 10.1016/j.spinee.2008.08.007. Epub 2008 Sep 19. Spine J. 2009. PMID: 18805066 Clinical Trial.
-
Indications for full prosthetic disc arthroplasty: a correlation of clinical outcome against a variety of indications.Eur Spine J. 2002 Oct;11 Suppl 2(Suppl 2):S131-6. doi: 10.1007/s00586-002-0428-4. Epub 2002 Sep 6. Eur Spine J. 2002. PMID: 12384734 Free PMC article. Clinical Trial.
-
Injectable biomaterials and vertebral endplate treatment for repair and regeneration of the intervertebral disc.Eur Spine J. 2006 Aug;15 Suppl 3(Suppl 3):S414-21. doi: 10.1007/s00586-006-0172-2. Epub 2006 Jul 26. Eur Spine J. 2006. PMID: 16868785 Free PMC article. Review.
Cited by
-
Finite Element Study of a Lumbar Intervertebral Disc Nucleus Replacement Device.Front Bioeng Biotechnol. 2016 Dec 1;4:93. doi: 10.3389/fbioe.2016.00093. eCollection 2016. Front Bioeng Biotechnol. 2016. PMID: 27990418 Free PMC article.
-
Characterization of injectable hydrogels based on poly(N-isopropylacrylamide)-g-chondroitin sulfate with adhesive properties for nucleus pulposus tissue engineering.J Mater Sci Mater Med. 2013 Apr;24(4):837-47. doi: 10.1007/s10856-013-4857-x. Epub 2013 Jan 31. J Mater Sci Mater Med. 2013. PMID: 23371764
-
Functional compressive mechanics and tissue biocompatibility of an injectable SF/PU hydrogel for nucleus pulposus replacement.Sci Rep. 2017 May 24;7(1):2347. doi: 10.1038/s41598-017-02497-3. Sci Rep. 2017. PMID: 28539658 Free PMC article.
-
Biomechanical behavior of a new nucleus prosthesis made of knitted titanium filaments.SAS J. 2007 Nov 1;1(4):125-30. doi: 10.1016/SASJ-2007-0106-RR. eCollection 2007. SAS J. 2007. PMID: 25802589 Free PMC article.
-
Injectable silk fibroin/polyurethane composite hydrogel for nucleus pulposus replacement.J Mater Sci Mater Med. 2012 Mar;23(3):711-22. doi: 10.1007/s10856-011-4533-y. Epub 2012 Jan 10. J Mater Sci Mater Med. 2012. PMID: 22231270
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical